ZC3H12A and type 1 diabetes mellitus: Our data suggest that splice variants of MCPIP1 could be involved in the fine tuning of the MCPIP1 action in beta-cells, a process likely to be dysregulated under unresolved inflammation during T1DM development, which may lead to uncontrolled expression of MCPIP1 and increased cytokine toxicity.